Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL(−1) and Glargine 100 U mL(−1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study

Схожие документы

• In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
  по: Schiavon, Michele, et al.
  Опубликовано: (2020)
• Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12‐month comparison by concomitant sulphonylurea and/or glinide use
  по: Terauchi, Yasuo, et al.
  Опубликовано: (2018)
• Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL
  по: Yu, Neng Chun
  Опубликовано: (2019)
• Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
  по: Kovatchev, Boris, et al.
  Опубликовано: (2020)
• Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
  по: Home, Philip D., et al.
  Опубликовано: (2017)